Similar articles

• Ursodeoxycholic acid treatment of primary hepatolithiasis in Caroli's syndrome.

  Ros E, Navarro S, Bru C, Gilabert R, Bianchi L, Bruguera M. Ros E, et al. Lancet. 1993 Aug 14;342(8868):404-6. doi: 10.1016/0140-6736(93)92817-d. Lancet. 1993. PMID: 8101905
• Intrahepatic cholesterol stones: a rationale for dissolution therapy.

  Strichartz SD, Abedin MZ, Ippoliti AF, Derezin M, Roslyn JJ. Strichartz SD, et al. Gastroenterology. 1991 Jan;100(1):228-32. doi: 10.1016/0016-5085(91)90605-k. Gastroenterology. 1991. PMID: 1983825
• Familial low phospholipid-associated cholelithiasis resulting from an autosomal dominant ABCB4 mutation.

  Miranda-Bautista J, Suárez-González J, Andrés-Zayas C, Buño I, Bañares R. Miranda-Bautista J, et al. Rev Esp Enferm Dig. 2019 Oct;111(10):806-808. doi: 10.17235/reed.2019.6334/2019. Rev Esp Enferm Dig. 2019. PMID: 31538486
• [Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts].

  Goszcz A. Goszcz A. Pol Tyg Lek. 1983 Feb 14;38(7):221-4. Pol Tyg Lek. 1983. PMID: 6346288 Review. Polish. No abstract available.
• [Diagnosis and therapy of gallstone].

  Toda G. Toda G. Nihon Naika Gakkai Zasshi. 1995 Mar 10;84(3):390-4. Nihon Naika Gakkai Zasshi. 1995. PMID: 7751775 Review. Japanese. No abstract available.